Stock Events

Stock Events

FibroBiologics 

$1.38
6
+$0.05+3.76% Thursday 20:00

Statistics

Day High
1.47
Day Low
1.19
52W High
30.6
52W Low
1.03
Volume
762,629
Avg. Volume
289,385
Mkt Cap
71.01M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

19MayExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.14
-0.08
-0.03
0.03
Expected EPS
-0.067825
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2022
2023
2024
0Revenue
-22.32MNet Income

Analyst Ratings

$4.00Average Price Target
The highest estimate is 4.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FBLG. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is involved in developing therapies for various diseases, including those related to fibrosis, which directly competes with FibroBiologics' focus on fibrotic diseases and regenerative medicine.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences has a strong presence in developing treatments for fibrotic diseases, particularly in liver fibrosis, positioning it as a direct competitor in the fibrosis therapy market.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals focuses on treating cystic fibrosis and other diseases that involve fibrotic processes, making it a key competitor in the fibrosis therapeutic area.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals is known for its innovation in biopharmaceuticals, including treatments for fibrotic diseases, competing in the same biologic space as FibroBiologics.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb develops various drugs for fibrotic diseases, including NASH, which overlaps with FibroBiologics' therapeutic areas.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie works on several biologic drugs that target inflammatory and fibrotic diseases, areas that are also key focuses for FibroBiologics.
Novartis
NVS
Mkt Cap237.61B
Novartis offers medications for multiple sclerosis and other chronic diseases involving fibrosis, competing in the same market as FibroBiologics.
AMGEN
AMGN
Mkt Cap160.66B
Amgen produces biologics that treat various fibrotic conditions, directly competing with FibroBiologics in the biotechnology and pharmaceutical sectors.
Merck
MRK
Mkt Cap214.76B
Merck & Co. develops treatments for chronic diseases that can involve fibrotic complications, positioning it as a competitor in the fibrosis treatment market.
Sanofi
SNY
Mkt Cap124.45B
Sanofi focuses on therapies for fibrotic diseases and other chronic conditions, making it a competitor in the same therapeutic areas as FibroBiologics.

About

FibroBiologics, Inc., a clinical-stage cell therapy company, develops and commercializes fibroblast-based therapies in the United States. It is developing CybroCell, for the treatment of degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for wound healing. The company is also on the early-stage research of CYTER915, which is designed to regenerate or reinvigorate production of the thymus and/or spleen; CYPS317, for the treatment of psoriasis; and TCB190 to treat certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.
Show more...
CEO
Mr. Peter O'Heeron
Employees
13
Country
US
ISIN
US31573L2043

Listings

F
DE
SG00.F
F
DE
SG0.F
BOATS
BOATS
FBLG.BOATS
XNAS
US
FBLG

0 Comments

Share your thoughts

FAQ

What is FibroBiologics stock price today?▼
The current price of FBLG is $1.38 USD — it has increased by +3.76% in the past 24 hours. Watch FibroBiologics stock price performance more closely on the chart.
What is FibroBiologics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange FibroBiologics stocks are traded under the ticker FBLG.
Is FibroBiologics stock price growing?▼
FBLG stock has fallen by -64.9% compared to the previous week, the month change is a -82.27% fall, over the last year FibroBiologics has showed a -92.11% decrease.
What is FibroBiologics market cap?▼
Today FibroBiologics has the market capitalization of 71.01M
When is the next FibroBiologics earnings date?▼
FibroBiologics is going to release the next earnings report on May 19, 2026.
What were FibroBiologics earnings last quarter?▼
FBLG earnings for the last quarter are -0.05 USD per share, whereas the estimation was -0.07 USD resulting in a +30.56% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is FibroBiologics revenue for the last year?▼
FibroBiologics revenue for the last year amounts to 0 USD.
What is FibroBiologics net income for the last year?▼
FBLG net income for the last year is -22.32M USD.
How many employees does FibroBiologics have?▼
As of April 03, 2026, the company has 13 employees.
In which sector is FibroBiologics located?▼
FibroBiologics operates in the Health Care sector.
When did FibroBiologics complete a stock split?▼
The last stock split for FibroBiologics was on March 30, 2026 with a ratio of 1:20.
Where is FibroBiologics headquartered?▼
FibroBiologics is headquartered in Houston, US.